Zinc inhibits nuclear factor-kappa B activation and sensitizes prostate cancer cells to cytotoxic agents
- PMID: 12429649
Zinc inhibits nuclear factor-kappa B activation and sensitizes prostate cancer cells to cytotoxic agents
Abstract
Prostate carcinogenesis involves transformation of zinc-accumulating normal epithelial cells to malignant cells, which do not accumulate zinc. In this study, we demonstrate by immunoblotting and immunohistochemistry that physiological levels of zinc inhibit activation of nuclear factor (NF)-kappa B transcription factor in PC-3 and DU-145 human prostate cancer cells, reduce expression of NF-kappa B-controlled antiapoptotic protein c-IAP2, and activate c-Jun NH(2)-terminal kinases. Preincubation of PC-3 cells with physiological concentrations of zinc sensitized tumor cells to tumor necrosis factor (TNF)-alpha, and paclitaxel mediated cell death as defined by terminal deoxynucleotidyl transferase-mediated nick end labeling assay. These results suggest one possible mechanism for the inhibitory effect of zinc on the development and progression of prostate malignancy and might have important consequences for the prevention and treatment of prostate cancer.
Similar articles
-
Diverse effects of zinc on NF-kappaB and AP-1 transcription factors: implications for prostate cancer progression.Carcinogenesis. 2006 Oct;27(10):1980-90. doi: 10.1093/carcin/bgl034. Epub 2006 Apr 10. Carcinogenesis. 2006. PMID: 16606632
-
Treatment of epigallocatechin-3-gallate inhibits matrix metalloproteinases-2 and -9 via inhibition of activation of mitogen-activated protein kinases, c-jun and NF-kappaB in human prostate carcinoma DU-145 cells.Prostate. 2004 Apr 1;59(1):33-42. doi: 10.1002/pros.10352. Prostate. 2004. PMID: 14991864
-
Transforming growth factor-beta1 activates interleukin-6 expression in prostate cancer cells through the synergistic collaboration of the Smad2, p38-NF-kappaB, JNK, and Ras signaling pathways.Oncogene. 2003 Jul 10;22(28):4314-32. doi: 10.1038/sj.onc.1206478. Oncogene. 2003. PMID: 12853969
-
The clinical relevance of the metabolism of prostate cancer; zinc and tumor suppression: connecting the dots.Mol Cancer. 2006 May 15;5:17. doi: 10.1186/1476-4598-5-17. Mol Cancer. 2006. PMID: 16700911 Free PMC article. Review.
-
Zinc as an anti-tumor agent in prostate cancer and in other cancers.Arch Biochem Biophys. 2007 Jul 15;463(2):211-7. doi: 10.1016/j.abb.2007.02.033. Epub 2007 Mar 16. Arch Biochem Biophys. 2007. PMID: 17400177 Free PMC article. Review.
Cited by
-
Essential Elements and Isoflavonoids in the Prevention of Prostate Cancer.Nutrients. 2022 Mar 14;14(6):1225. doi: 10.3390/nu14061225. Nutrients. 2022. PMID: 35334882 Free PMC article.
-
Zinc Inhibits Expression of Androgen Receptor to Suppress Growth of Prostate Cancer Cells.Int J Mol Sci. 2018 Oct 8;19(10):3062. doi: 10.3390/ijms19103062. Int J Mol Sci. 2018. PMID: 30297600 Free PMC article.
-
Radiosensitization of clioquinol and zinc in human cancer cell lines.BMC Cancer. 2018 Apr 20;18(1):448. doi: 10.1186/s12885-018-4264-2. BMC Cancer. 2018. PMID: 29678153 Free PMC article.
-
Glucose Metabolism in the Progression of Prostate Cancer.Front Physiol. 2017 Feb 21;8:97. doi: 10.3389/fphys.2017.00097. eCollection 2017. Front Physiol. 2017. PMID: 28270771 Free PMC article. Review.
-
Engineered metal nanoparticles in the sub-nanomolar levels kill cancer cells.Int J Nanomedicine. 2016 Apr 18;11:1567-76. doi: 10.2147/IJN.S101463. eCollection 2016. Int J Nanomedicine. 2016. PMID: 27143879 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Miscellaneous